Immediate Impact
1 by Nobel laureates 1 from Science/Nature 53 standout
Citing Papers
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Works of Robin Hubler being referenced
371. Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection
2022
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robin Hubler | 109 | 127 | 42 | 59 | 11 | 247 | |
| Guillermo Ezpeleta | 124 | 150 | 36 | 43 | 17 | 236 | |
| Norazah Ahmad | 74 | 82 | 39 | 66 | 10 | 256 | |
| P. Cocchi | 52 | 119 | 23 | 56 | 18 | 237 | |
| Barry Vipond | 129 | 75 | 9 | 34 | 14 | 274 | |
| T. Perpoint | 77 | 127 | 27 | 43 | 17 | 297 | |
| Pranav Tandon | 54 | 141 | 78 | 48 | 13 | 286 | |
| M. Nouvellon | 127 | 76 | 23 | 24 | 16 | 245 | |
| Alex Yat-Man Ho | 60 | 92 | 25 | 55 | 18 | 243 | |
| Linda Graviss | 99 | 115 | 65 | 22 | 14 | 299 | |
| Charles A. Kallick | 100 | 90 | 13 | 34 | 22 | 295 |
All Works
Loading papers...